Identification of Biomarkers to Predict Driver Take-over Control Quality

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 9, 2019

Primary Completion Date

August 6, 2020

Study Completion Date

August 6, 2020

Conditions
Healthy SubjectsAttention Deficit
Interventions
BEHAVIORAL

Driving simulator sessions

The volunteers will be placed in a driving simulator that will simulate autonomous highway driving. This autonomous driving will be interrupted by take-over requests related to events that disrupt autonomous driving. During autonomous driving, the driver will have to disengage from driving by performing non-related driving tasks. During each non-related driving tasks, a take-over request will be sent. Electrophysiological (EEG, ECG, EDA, EMG, respiration) and behavioural data will be recorded before, during and after the take-over control.

Trial Locations (1)

33000

Bordeaux University Hospital, Bordeaux

All Listed Sponsors
collaborator

University of Bordeaux

OTHER

collaborator

University Hospital, Bordeaux

OTHER

lead

PSA Automobiles S.A.

INDUSTRY

NCT04188626 - Identification of Biomarkers to Predict Driver Take-over Control Quality | Biotech Hunter | Biotech Hunter